Ho Chi Minh City Medial Import Export Joint Stock Co

    Ho Chi Minh City Medial Import Export Joint Stock Co

    UUPCOM:YTC
    21,000.00
    VND
    -700.00
    (-3.23%)
    Ho Chi Minh City Medial Import Export Joint Stock Co
    UPCOM:YTC
    (Unlisted Public Company Market)

    Recent

    price

    21,000.00

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    No data availableFinancial data will appear here once available

    Capital Structure

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Revenue

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    FRC

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available
    Similar Companies
    Business
    Ho Chi Minh City Medical Import Export Joint Stock Company (YTECO) is a Vietnam-based healthcare supply chain and distribution enterprise specializing in the import, export, wholesale, and retail distribution of pharmaceuticals, active pharmaceutical ingredients, medical devices, and healthcare products. Established in 1984 and headquartered in Ho Chi Minh City, Vietnam, the company operates across the healthcare, biotechnology, and medical logistics sectors, serving public and private hospitals, specialized clinics, research institutions, healthcare centers, retail pharmacy chains, and commercial distribution partners nationwide. The company operates through three principal business segments: Pharmaceutical Distribution, Medical Equipment and Healthcare Supplies, and Healthcare Logistics and Warehousing Services. Its core product and service portfolio comprises the importation, registration, marketing, and distribution of finished prescription medicines and over-the-counter pharmaceuticals spanning cardiovascular, oncology, anti-infective, gastrointestinal, respiratory, and central nervous system therapeutics; active pharmaceutical ingredients (APIs), intermediate chemicals, and pharmaceutical excipients for domestic medicine manufacturing; diagnostic imaging systems, surgical instruments, patient monitoring equipment, laboratory diagnostic reagents, and specialized electromedical devices; disposable medical supplies, wound care products, and personal protective equipment; vaccines, biological products, blood derivatives, and nutritional supplements; and supply chain management services comprising Good Storage Practice (GSP) and Good Distribution Practice (GDP) certified warehousing, temperature-controlled cold chain logistics, bonded storage, customs clearance, regulatory filing, and nationwide pharmaceutical freight forwarding. In recent operational developments, Ho Chi Minh City Medical Import Export Joint Stock Company has expanded its cold-chain infrastructure and modernized its central logistics hubs with automated warehouse management systems to meet international compliance standards for specialized biologics and temperature-sensitive specialty therapeutics. The company has broadened its commercial partnerships by securing exclusive and direct distribution agreements with multinational pharmaceutical and medical device manufacturers across Europe, North America, and Asia-Pacific. Furthermore, the enterprise has accelerated its digital transformation through the deployment of integrated enterprise resource planning and electronic B2B procurement platforms, while expanding its public hospital tender participation and private healthcare supply networks across southern and central Vietnam.